Related references
Note: Only part of the references are listed.The Protective Role of Adiponectin for Lipoproteins in End-Stage Renal Disease Patients: Relationship with Diabetes and Body Mass Index
Susana Coimbra et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
Diabetes as a cardiovascular risk factor: An overview of global trends of macro and micro vascular complications
Elisa Dal Canto et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2019)
Matrix Gla protein T-138C polymorphism is associated with carotid intima media thickness and predicts mortality in patients with diabetic nephropathy
Stefanos Roumeliotis et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2017)
Circulating adiponectin levels in relation to carotid atherosclerotic plaque presence, ischemic stroke risk, and mortality: A systematic review and meta-analyses
Jessica Gorgui et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2017)
Oxidative Stress in Hemodialysis Patients: A Review of the Literature
Vassilios Liakopoulos et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
Impact of statin therapy on plasma adiponectin concentrations: A systematic review and meta-analysis of 43 randomized controlled trial arms
Piotr Chrusciel et al.
ATHEROSCLEROSIS (2016)
Adiponectin and end-stage renal disease
Anastasia Markaki et al.
Hormones-International Journal of Endocrinology and Metabolism (2016)
Change in adiponectin explains most of the change in HDL particles induced by lifestyle intervention but not metformin treatment in the Diabetes Prevention Program
Ronald B. Goldberg et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2016)
Circulating adiponectin and carotid intima-media thickness: A systematic review and meta-analysis
Karina Gasbarrino et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2016)
Adiponectin predicts cardiovascular events in diabetes dialysis patients
I. M. Kacso et al.
CLINICAL BIOCHEMISTRY (2015)
Association of Plasma Adiponectin and Oxidized Low-Density Lipoprotein with Carotid Intima-Media Thickness in Diabetic Nephropathy
Anna Tavridou et al.
JOURNAL OF DIABETES RESEARCH (2015)
Adiponectin, type 2 diabetes and cardiovascular risk
Soren Lindberg et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2015)
Adiponectin as a routine clinical biomarker
Ken Kishida et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Plasma Adiponectin Levels for Prediction of Cardiovascular Risk Among Hemodialysis Patients
Eid M. El-Shafey et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2014)
Adiponectin increases macrophages cholesterol efflux and suppresses foam cell formation in patients with type 2 diabetes mellitus
Min Wang et al.
ATHEROSCLEROSIS (2013)
Protective Role of Adiponectin in Cardiovascular Disease
R. Shibata et al.
CURRENT MEDICINAL CHEMISTRY (2012)
Adiponectin and the mediation of HDL-cholesterol change with improved lifestyle: the Look AHEAD Study
L. Maria Belalcazar et al.
JOURNAL OF LIPID RESEARCH (2012)
Adiponectin and Cardiovascular Outcomes among Hemodialysis Patients
Emad Abdallah et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2012)
Association of Adiponectin with Carotid Arteriosclerosis in Predialysis Chronic Kidney Disease
Mutsuharu Hayashi et al.
AMERICAN JOURNAL OF NEPHROLOGY (2011)
Impact of HDL on adipose tissue metabolism and adiponectin expression
Sophie Van Linthout et al.
ATHEROSCLEROSIS (2010)
Effect of statins on HDL-C: a complex process unrelated to changes in LDL-C: analysis of the VOYAGER Database
Philip J. Barter et al.
JOURNAL OF LIPID RESEARCH (2010)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
Very Low Density Lipoprotein Metabolism and Plasma Adiponectin as Predictors of High-Density Lipoprotein Apolipoprotein A-I Kinetics in Obese and Nonobese Men
Dick C. Chan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
The effect of joint exposures: examining the presence of interaction
Renee de Mutsert et al.
KIDNEY INTERNATIONAL (2009)
Association of adiponectin and resistin with cardiovascular events in Korean patients with type 2 diabetes: The Korean atherosclerosis study (KAS) A 42-month prospective study
Soo Lim et al.
ATHEROSCLEROSIS (2008)
Association of serum adiponectin levels with all-cause mortality in hemodialysis patients
Naro Ohashi et al.
INTERNAL MEDICINE (2008)
Testing for causality and prognosis: etiological and prognostic models
Giovanni Tripepi et al.
KIDNEY INTERNATIONAL (2008)
Serum adiponectin predicts all-cause mortality and end stage renal disease in patients with type I diabetes and diabetic nephropathy
Anders Jorsal et al.
KIDNEY INTERNATIONAL (2008)
Adiponectin accelerates reverse cholesterol transport by increasing high density lipoprotein assembly in the liver
Fumihiko Matsuura et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Adiponectin and mortality in patients with chronic kidney disease
Vandana Menon et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Adiponectin and coronary heart disease: A prospective study and meta-analysis
Naveed Sattar et al.
CIRCULATION (2006)
Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome
Takashi Kadowaki et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Relationship between adiponectin and glycemic control, blood lipids, and inflammatory markers in men with type 2 diabetes
MB Schulze et al.
DIABETES CARE (2004)
Adiponectin and atherosclerotic disease
K Shimada et al.
CLINICA CHIMICA ACTA (2004)
Adiponectin represents an independent cardiovascular risk factor predicting serum HDL-cholesterol levels in type 2 diabetes
B Zietz et al.
FEBS LETTERS (2003)
HDL and arteriosclerosis: beyond reverse cholesterol transport
JR Nofer et al.
ATHEROSCLEROSIS (2002)
Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages
N Ouchi et al.
CIRCULATION (2001)
Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients
K Hotta et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
Inflammation is associated with carotid atherosclerosis in dialysis patients
C Zoccali et al.
JOURNAL OF HYPERTENSION (2000)